Your Night Prayer

Learn More About Sic Deus Dilexit Mundum

Logo Trinitas Cellars

Today’s Night Prayer is brought to you by Trinitas Cellars

A Night Prayer

Jesus Christ, my God, I adore You and thank You for all the graces You have given me this day. I offer You my sleep and all the moments of this night. I place myself and all my loved ones, wherever they may be, in Your sacred side and under the mantle of Our Blessed Mother. Let Your holy angels stand watch and keep us in peace. Amen.

Subscribe to the Morning Offering video podcast

Quote of the Day

“And when the centurion, who stood facing him, saw that he thus breathed his last, he said, ‘Truly this man was the Son of God!’” -Mark 15:39 

Today’s Meditation

Then, before my eyes, I saw my beloved Child raised up on the cross and fixed to its hard wood with piercing and unrelenting nails. All the while, He remained like a gentle lamb in the presence of its shearers, not uttering a word nor opening His mouth. Thus I, the handmaid of the Lord, looked upon my Master being tortured! Thus I, the Mother of God, saw my Son hanging from the cross, dying in the throngs of a shameful and ignominious death. The pain and agony which tore through my heart ehn was so intense that no words could ever express it. His blood gushed forth from the four wounds He then bore — upon each of His hands and feet, where the nails had penetrated His holy flesh. As a crimson flood, His precious blood poured onto the wood of the cross and covered the iron of the nails. —Mary to St. Bernard

An excerpt from The Passion of Christ Through the Eyes of Mary

Celebrate Easter with Grace in Every Glass

Make Easter Cuvée the centerpiece of your celebration, a beautifully crafted sparkling wine created for moments of renewal, joy, and gathering around the table. Elegant, vibrant, and festive, it’s the perfect way to toast the season of hope. 

Discover more from Trinitas Cellars’ faith-inspired collection, including the Pope Leo Wine and the Marian Series, each bottle reflecting devotion, tradition, and purpose. 

Share the gift of wine this Easter and enjoy 20% off your first order with code TRINITY at TrinitasCellars.com.

Learn More 

Recommended Products

The Last Hours of Jesus - From Gethsemane to Golgotha

The Last Hours of Jesus – From Gethsemane to Golgotha

Holy Week Devotional Wood Block Set

Holy Week Devotional Wood Block Set

Examination of Conscience

The daily examination of conscience is an ancient Catholic practice. It’s very simple, and it’s designed to help us identify our sins and weaknesses so that we can improve and grow stronger in the spiritual life, while providing an excellent ongoing preparation for regular Confession. It consists of taking a few minutes at the end of the day to prayerfully review our actions in the light of God’s commandments, followed by the Act of Contrition.

 Reflect on the victories and losses

Actively reflecting on the high and low points of the day can help you live more intentionally and bring a renewed sense of resolve into the following day.

  • Review your actions, words, and thoughts today. Did you actively guard yourself against temptation? Where did sin creep in?
  • In what moments did you practice virtue and moral courage?
  • Were you attuned to the Holy Spirit’s promptings today? Where did you feel His inspiration?
  • Ask Him for the graces necessary to follow His Will more purposefully tomorrow.

 Act of Contrition

O my God, I am heartily sorry for having offended Thee, and I detest all my sins because of Thy just punishments, but most of all because they offend Thee, my God, Who art all good and deserving of all my love. I firmly resolve with the help of Thy grace to sin no more and to avoid the near occasions of sin. Amen.

 Practice gratitude

It is God’s love that has brought you into existence and to this exact moment. Practice looking for His hand in your day. 

  • Where did you feel His loving gaze upon you today?
  • What people or moments helped you see God in your life?
  • Thank God for all these moments!
  • Ask Him to help you recognize His blessings and providence tomorrow.

 Renew your commitment to Christ

Remember: our Faith is founded upon a Person—Christ! Renew your personal love and devotion to Him.

  • Thank God for the gift of His Son Jesus and our call to be His disciples.
  • Tell the Lord of your desire to know Christ more personally.
  • If possible, set an intention for your day tomorrow. Ask Our Lord to guide you in this act.
  • Pray a Hail Mary, Our Father, or another beloved prayer.

Rest with God

In peace I will both lie down and sleep; for Thou alone, O Lord, makest me dwell in safety. — Psalm 4:8

Compline

Read Now 

Want to help your organization reach 2.6 million Catholics? Click here to consider sponsoring future Night Prayers!

Please add NightPrayer@goodcatholic.comto your address book or list of approved senders.

Unsubscribe | Privacy Policy | Contact Us

Can’t see this email? View in Your Browser

Good Catholic

A service of the Network

615 E Westinghouse Blvd Charlotte, North Carolina 28273 US

© 2026 Trinity Road, LLC. All rights reserved.

Hims and Hers Shares Surge on Novo Nordisk Deal

DividendStocks.com Newsletter

Unsubscribe

These 5 stocks could move before Wall Street catches on (From TradingTips)


Patience Pays: Hims & Hers Surges on News of Novo Nordisk Deal

Written by Jordan Chussler on March 10, 2026 

Hims & Hers logo overlaid on medical syringes, measuring tape, and financial charts symbolizing telehealth weight-loss market growth.

Key Points

  • Hims & Hers has shifted from offering controversial compounded GLP-1s to a formal agreement with Novo Nordisk, allowing the platform to distribute FDA-approved Ozempic and Wegovy.
  • Following the announcement, HIMS shares surged nearly 46%, helping the stock recover from a 59% drop earlier in the year caused by previous legal friction with Novo Nordisk.
  • Analysts have upgraded the stock, citing the partnership as a major growth catalyst; despite a year-to-date loss, earnings are projected to grow by over 79% next year.
  • Special ReportWhy I’m avoiding Nvidia (and buying these 3 AI stocks instead) (From TradingTips)

After falling 59% from its year-to-date (YTD) high, embattled healthcare stock Hims & Hers Health (NYSE: HIMS) is making headlines as shares are surging in the wake of an agreement with GLP-1 maker Novo Nordisk (NYSE: NVO)—the very company that filed a patent infringement lawsuit against Hims & Hers on Feb. 9.

After having to pull its compounded semaglutide modeled after Novo Nordisk’s weight loss drugs, Wegovy and Ozempic, Hims & Hers announced in a press releasethat the two firms have entered into a strategic partnership, making Novo Nordisk’s obesity drugs available through the telehealth platform. 

Since the announcement, HIMS has gained nearly 46% along with analyst upgrades as Wall Street turns bullish on the direct-to-consumer prescription drug provider. 

Early The Safest Investment Right Now? (It’s NOT Gold) (Ad)

Weiss expert Chris Graebe just revealed a unique gold-related investment that offers much higher upside than gold itself without the downside price risk—private, pre-IPO shares insulated from daily market volatility in a company that has pioneered a new way to extract and process gold 10 times faster and up to 70 times cheaper than a traditional miner without owning or operating a single mine. This is a rare chance to invest in the Alpha Round of funding, one of the earliest and most rewarding pre-IPO funding rounds, with examples of Alpha Round deals that delivered returns as high as 552,332%, enough to grow a $1,000 stake into $5.5 million.Watch the Private Investment Summit for all the facts now

A Strategic Shift From Compounded GLP-1 to FDA-Approved Drugs

Amid surging demand and subsequent shortages for weight loss drugs, compounded GLP-1 alternatives emerged to fill the void. However, compounded GLP-1 drugs lack U.S. Food and Drug Administration (FDA) approval. 

While they increased affordable access to substitutes for brand-name drugs like Ozempic and Wegovy, while offering similar ingredient profiles (e.g., semaglutide and tirzepatide, the latter of which is marketed as Mounjaro and Zepbound), the absence of FDA approval means that those alternative drugs lacked quality and efficacy reviews, thereby posing a risk of incorrect dosages, improper storage, and other safety issues. 

According to Hims & Hers’s press release, as a part of the company’s shift away from compounded GLP-1 offerings, “existing patients will have the opportunity to transition to FDA-approved medicines.”

Specifically, “Hims & Hers has entered into an agreement with Novo Nordisk that will bring Ozempic (semaglutide) 0.5 mg, 1 mg, and 2 mg injections and Wegovy (semaglutide) pills and injections to the platform later this month, including 1.7 mg or 2.4 mg injections and 1.5 mg, 4 mg, 9 mg, and 25 mg tablets.”

Co-founder and CEO Andrew Dudum noted that the deal should result in “tremendous growth opportunities in the U.S. with the expanding assortment of branded GLP-1 medications.” Dudum added that the “collaboration reflects what’s possible globally when drugmakers, biotech companies, and diagnostic leaders partner with consumer platforms to support scaled distribution of their latest medical innovations.”

Shares of HIMS Are Still Struggling, But the Future Looks Promising

The recent news, as well as the sizable bump in the stock’s price, was warmly welcomed by shareholders who have dealt with Hims & Hers’ volatility over the past year. Even in the wake of the Novo Nordisk-induced sell-off in February, analysts remained bullish on the stock, with some 12-month price targets implying as much as 150% potential upside.

Even with the March 9 surge, HIMS shares are still down nearly 33% over the last 12 months. But fundamentally, Hims & Hers looks well-positioned to sustain its run.  

When the company reported full-year and Q4 2025 earnings on Feb. 23, it announced an earnings per share (EPS) beat and a revenue miss. EPS of 8 cents surpassed analyst expectations of 2 cents, while revenue of $617.82 million fell short of expectations of $619.48 million. 

It was the company’s first EPS beat since the first quarter of last year. But just as importantly, the financial metrics showed steady, sustainable revenue growth, with a three-year average of 64.60%. And while earnings contracted in 2025, that followed EPS growth of nearly 582% in 2024 and nearly 66% in 2023. 

Hims & Hers Health’s earnings are expected to grow 79.31% next year, from 29 cents per share to 52 cents per share.

Tesla is quietly pivoting – and here’s how I’m playing it (Ad)

Tesla built its name on electric cars, but earlier this year, Elon signaled something that caught my attention—production on certain vehicle models would be scaled back to make room for something else: robots. Wall Street doesn’t always price transitions like these correctly at first, and for traders, that tension is where opportunity lives—I’ve already revealed how this cars-to-robots shift could influence Tesla’s price action over the next few months plus the levels I’m watching if volatility expands.See the entire Tesla setup right here now

HIMS Receives Analyst Upgrades as Wall Street Turns Bullish on Telehealth

Following the announcement of the Novo Nordisk deal, Bank of America Securities upgraded HIMS stock to Neutral from Underperform and raised its price target to $23 from $12.50.

Notably, the firm’s previous price target excluded contributions from GLP-1 revenue, showing that the agreement with Novo Nordisk is being seen as an extremely bullish catalyst on Wall Street.

Overall, the stock receives a consensus Hold rating based on 17 analysts currently covering the stock. The average one-year price target implies more than 32% potential upside.  

Current short interest of 43.24% of the shares outstanding should be monitored, but that figure—which equates to $1.32 billion worth of shares—is substantially lower than the $4.27 billion that were shorted last July. That downtrend has steadily continued, and it would not be surprising if institutional buyers once again outnumber sellers in the quarters ahead as the deal with Novo Nordisk will bolster Hims & Hers’ top-line growth. 

Read this article online ›

Recommended Stories

MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market.

Did you enjoy this article?

I liked this article.
I did not like this article.

Thank you for subscribing to DividendStocks.com’s daily newsletter for dividend and income investors that covers ex-dividend stocks, new dividend declarations, dividend stock ideas, and the latest market news.

If you have questions about your account, please contact MarketBeat’s South Dakota based support team at contact@marketbeat.com.

If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.

© 2006-2026 MarketBeat Media, LLC. 
345 N Reid Pl. #620, Sioux Falls, SD 57103-7078. United States..

Today’s Featured Link: Paper Gold Faces Default Shadow Miner Gains Steam (From Behind the Markets)

Stars are out for USA-DR semifinal

MLB

Sunday, March 15

View Online

WORLD BASEBALL CLASSIC FULL SCHEDULE

Team USA turns to its ace Paul Skenes for an electric matchup with Fernando Tatis Jr., Vladimir Guerrero Jr. and the dynamic sluggers of DR, who have been crushing all the pitching in their path. A spot in the World Baseball Classic final is on the line, and every game’s a Game 7 now. 

VEN
ITA
FS1
Preview

World Baseball Classic Upcoming ScheduleMonday
Mar 16
8:00 PM EDTVEN  @
ITA 

World Baseball Classic Gear. Shop Now

facebook
instagram
twitter
youtube
tiktok
snapchat

© 2026 MLB Advanced Media, L.P. MLB trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com. Any other marks used herein are trademarks of their respective owners.

Please review our Privacy Policy.

You (pahovis@aol.com) received this message because you registered to receive commercial email messages from MLB.com.

Please add info@marketing.mlbemail.com to your address book to ensure our messages reach your inbox. If you no longer wish to receive commercial email messages from World Baseball Classic, please unsubscribe or log in and manage your email subscriptions.

Postal Address: World Baseball Classic, c/o MLB Advanced Media, L.P., 1271 Avenue of the Americas, New York, NY 10020.

The traders who thrive in chaos all have one thing in common.

Company Logo

Jeff Bierman here,

The traders who succeed have a technical foundation. A framework they trust. A system they can return to when the market gets loud.

The traders who struggle are the ones piecing it together in real time — reacting instead of reading, guessing instead of knowing.

That gap is exactly what I’ve designed my masterclasses to close. And right now, through the TheoTRADE Super Bundle, you can access a stack of them — alongside 63 total systems, indicators, and scans — with lifetime access.

Here’s some of what I’ve put together inside the bundle:

The Fibonacci Trading Masterclass — a 5-part series walking you through retracements and extensions so you can consistently set targets and define your exits before you ever place a trade.

The Victory Over Volatility Masterclass — time-tested volatility indicators combined with traditional technical analysis, so you stop fearing the market we’re in and start using it.

Technical Trading Mastery — a detailed walkthrough of trading system design so you can apply a true systems approach and cut your stress in half.

Technical Analysis 101 and 201 — whether you’re just getting started or ready to go deeper, these build the kind of foundation that actually holds up under pressure.

The Hidden Art and Shocking Science of Trend Trading — including how to tell the difference between an algorithmically driven trend and an organic one. Knowing that difference can change everything.

That’s five of the masterclasses I personally host inside this bundle. Don Kaufman and the rest of the TheoTRADE team have added dozens more.

[GIVE ME ACCESS TO ALL 63 SYSTEMS]

To Your Success,

Professor Jeff Bierman, CMT TheoTRADE



Helping You Become a Better Trader…it’s What We Do. Experience TheoTrade® Today!

Whether you are a beginning, intermediate, or active trader, you will find a treasure chest of valuable trading education resources, both free and paid, that will help take your trading to the next level. We are committed to helping you become the best trader you can be.


Disclaimer: Neither TheoTrade.com  or any of its officers, directors, employees, other personnel, representatives, agents or independent contractors is, in such capacities, a licensed financial adviser, registered investment adviser, registered broker-dealer or FINRA |SIPC |NFA-member firm. TheoTrade does not provide investment or financial advice or make investment recommendations. TheoTrade is not in the business of transacting trades, nor does TheoTrade agree to direct your brokerage accounts or give trading advice tailored to your particular situation. Nothing contained in our content constitutes a solicitation, recommendation, promotion, or endorsement of any particular security, other investment product, transaction or investment.Trading Futures, Options on Futures, and retail off-exchange foreign currency transactions involves substantial risk of loss and is not suitable for all investors. You should carefully consider whether trading is suitable for you in light of your circumstances, knowledge, and financial resources. You may lose all or more of your initial investment. Opinions, market data, and recommendations are subject to change at any time. Past Performance is not necessarily indicative of future results.

TheoTrade

PO Box 24790 Christiansted, Virgin Islands 00824
1 (800) 256-8876

support@theotrade.com

Want to change how you receive these emails?

You can Update your preferences

Terms of Service |  Privacy Policy

If you no longer wish to receive our emails Unsubscribe

Trump Exposes Hidden Iranian Sleeper Cells While Democrats Leave America Wide Open to Terror – American Voter Polls News

Trump Exposes Hidden Iranian Sleeper Cells While Democrats Leave America Wide Open to Terror – American Voter Polls News
— Read on americanvoterpolls.com/trump-exposes-hidden-iranian-sleeper-cells-while-democrats-leave-america-wide-open-to-terror/

Shocking Statement: Trump vs. Zelenskyy—Find Out What Happened

IWJ - logo
title
IWJ - logo2

INVESTING WISELY BEGINS WITH KNOWLEDGE.In a surprising twist, Trump takes a bold stand against Zelenskyy in a shocking statement that’s taking the world by storm. 

Why is Trump calling out Zelenskyy? What does this mean for the future of global peace and America’s role in international politics?

This unexpected move is sparking debates and could have major consequences for diplomatic relations, the economy, and the ongoing conflict in Ukraine. 

Click HERE to uncover the reasons behind Trump’s stance and what it means for you. 

P.S. Trump’s stance on Ukraine could lead to major shifts in global policies and markets. Stay ahead and protect your interests. 

Editor’s Note: From time to time, we come across opportunities at Investing Wise Journal that we feel could be of real interest to our readers. The message above from a trusted partner is one worth your attention.

This message comes from Investing Wise Journal, operated by Not Only Ads LLC.

You subscribed (or showed interest) in our financial education content.

Need help? Reply to this email anytime. Other inquiries: support@investingwisejournal.com


Privacy Policy | Terms & Conditions | Unsubscribe

15257 Amberly Dr Ste 140 Tampa ,FL 33647 

© 2026 InvestingWiseJournal.com

Is This True or False?

True or False?

The Panama Canal was primarily built to improve automobile transportation.

(Select Your Choice Below)

True

False

DISCLAIMER

You have signed up to receive emails from todaysflashback.com and agreed to receive our daily newsletters which include promotions. Content labeled as “SPONSORED” may be a third-party advertisement and is not endorsed or warranted by any individual or company as a whole.© 2024 Todays Flashback. All Rights Reserved.2803 Philadelphia Pike Suite B #1340 Claymont, DE 19703, USA

Unsubscribe

WAR WITH IRAN: What It Could Mean for the U.S. Dollar

Video preview

INVESTING WISELY BEGINS WITH KNOWLEDGE.
OUR MISSION IS HERE TO DELIVER THE CLARITY THAT BUILDS LASTING WEALTH.
WAR WITH IRAN Tensions involving Iran are escalating, and global markets are closely monitoring the situation. 

Historically, major conflict in the Middle East can place pressure on energy markets, inflation, and even the U.S. dollar.

When events like this unfold, market volatility can increase quickly. 

For Americans with retirement savings tied to the market, it may be a good time to review how those savings are positioned. 

If you own a 401(k), IRA, or TSP, there may be strategies worth understanding during periods of geopolitical instability. 

Download the FREE Wealth Guide

Reagan Gold Group does not provide financial, legal, or tax advice. This material is for educational purposes only and should not be considered investment advice. All investments carry risk, including loss of principal. Past performance is not indicative of future results. Please consult a licensed financial advisor before making investment decisions.

This is an advertisement. If you no longer wish to receive promotional messages from this advertiser, please click here: Unsubscribe. Or write to: 2029 Century Park E Suite 400, Los Angeles, CA 90067

Editor’s Note: From time to time, we come across opportunities at Investing Wise Journal that we feel could be of real interest to our readers. The message above from a trusted partner is one worth your attention.

This message comes from Investing Wise Journal, operated by Not Only Ads LLC.

You subscribed (or showed interest) in our financial education content.

Need help? Reply to this email anytime. Other inquiries: support@investingwisejournal.com


Privacy Policy | Terms & Conditions | Unsubscribe

15257 Amberly Dr Ste 140 Tampa ,FL 33647 

© 2026 InvestingWiseJournal.com

Investing Wise Journal, 15257 Amberly Dr Ste 140 · Florida · Tampa · 33647 · United StatesNo longer want to receive these emails. Unsubscribe

WAR WITH IRAN: What It Could Mean for the U.S. Dollar

Video preview

INVESTING WISELY BEGINS WITH KNOWLEDGE.
OUR MISSION IS HERE TO DELIVER THE CLARITY THAT BUILDS LASTING WEALTH.
WAR WITH IRAN Tensions involving Iran are escalating, and global markets are closely monitoring the situation. 

Historically, major conflict in the Middle East can place pressure on energy markets, inflation, and even the U.S. dollar.

When events like this unfold, market volatility can increase quickly. 

For Americans with retirement savings tied to the market, it may be a good time to review how those savings are positioned. 

If you own a 401(k), IRA, or TSP, there may be strategies worth understanding during periods of geopolitical instability. 

Download the FREE Wealth Guide

Reagan Gold Group does not provide financial, legal, or tax advice. This material is for educational purposes only and should not be considered investment advice. All investments carry risk, including loss of principal. Past performance is not indicative of future results. Please consult a licensed financial advisor before making investment decisions.

This is an advertisement. If you no longer wish to receive promotional messages from this advertiser, please click here: Unsubscribe. Or write to: 2029 Century Park E Suite 400, Los Angeles, CA 90067

Editor’s Note: From time to time, we come across opportunities at Investing Wise Journal that we feel could be of real interest to our readers. The message above from a trusted partner is one worth your attention.

This message comes from Investing Wise Journal, operated by Not Only Ads LLC.

You subscribed (or showed interest) in our financial education content.

Need help? Reply to this email anytime. Other inquiries: support@investingwisejournal.com


Privacy Policy | Terms & Conditions | Unsubscribe

15257 Amberly Dr Ste 140 Tampa ,FL 33647 

© 2026 InvestingWiseJournal.com

Investing Wise Journal, 15257 Amberly Dr Ste 140 · Florida · Tampa · 33647 · United StatesNo longer want to receive these emails. Unsubscribe